Evidence map›Paper›PMID 39540213›Full record

ArticleHaematologica2025

Ixazomib, pomalidomide and dexamethasone in relapsed or refractory multiple myeloma characterized with highrisk cytogenetics: the IFM 2014-01 study.

Arthur Bobin, Salomon Manier, Joe De Keizer, Jaydeep K Srimani, Cyrille Hulin, Lionel Karlin, Denis Caillot, Ingrid Lafon, Clara Mariette, Carla Araujo and 32 more

Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03683277 (Multicenter Open Label Phase 2 Single Arm Study of Ixazomib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Characterized With Genomic Abnormalities of Adverse Adverse Prognostic), which is not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03683277 phase2terminatednot on this map

Multicenter Open Label Phase 2 Single Arm Study of Ixazomib, Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Characterized With Genomic Abnormalities of Adverse Adverse Prognostic

TypeinterventionalSponsorIntergroupe Francophone du MyelomeRan2019 to 2023Enrolled26ConditionsMultiple Myeloma, Relapsed and Refractory Multiple Myeloma, Genetic ConditionArmsIxazomib/Pomalidomide/Dexamethasone
3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Arthur BobinUniversity, U1313, U1402, Poitiers.
Salomon ManierDepartment of Hematology, University hospital and INSERM UMR-S1277, Lille.
Joe De KeizerClinical investigation center CIC INSERM 1402, University hospital, Poitiers.
Jaydeep K SrimaniTakeda Development Center Americas, Cambridge MA.
Cyrille HulinDepartment of Hematology, Haut-Lévêque hospital, Pessac.
Lionel KarlinDepartment of clinical Hematology, Civils Hospices, Lyon.
Denis CaillotDepartment of Oncology Hematology, Bourgogne Cancerology Institute, Dijon.
Ingrid LafonDepartment of Oncology Hematology, Bourgogne Cancerology Institute, Dijon.
Clara MarietteDepartment of Hematology, University hospital, Grenoble.
Carla AraujoDepartment of Hematology, Côte basque hospital, Bayonne.
Bertrand ArnulfDepartment of Hematology, Saint-Louis hospital, Paris.
Benoît BareauDepartment of Hematology, private hospital, Cesson-Sévigné.
Karim BelhadjLymphoid hemopathies Unit, Henri Mondor University hospital, Créteil.
Lofti BenboubkerDepartment of Hematology and cell therapy, Tours University hospital.
Thorsten BraunDepartment of clinical Hematology, Avicenne hospital, Bobigny.
Claire CalmettesDepartment of Onco-Hematology, hospital, Périgueux.
Olivier DecauxDepartment of Clinical Hematology, UMR U1236 INSERM, University, Rennes.
Mamoun DibBlood disease department, University hospital, Angers.
Hélène DemarquetteDepartment of Hematology, hospital, Dunkerque.
Caroline JacquetDepartment of Hematology, University hospital - Brabois hospitals, Vandoeuvre les Nancy.
Cécile SonntagDepartment of Hematology, ICANS University hospital, Strasbourg.
Sophie GodetDepartment of clinical Hematology, University hospital, Robert Debré Hospital, Reims.
Arnaud JaccardDepartment of clinical Hematology and cell therapy, University hospital, Limoges.
Pascal LenainDepartment of Hematology, Henri Becquerel center, Rouen.
Margaret MacroDepartment of clinical Hematology, University hospital, Caen.
Valentine Richez-OlivierDepartment of clinical Hematology, Archet hospital, Nice.
Mourad TiabDepartment of Onco-Hematology, Vendée departmental hospital, La Roche/Yon.
Laure VincentDepartment of clinical Hematology, University, Montpellier.
Hacene ZerazhiDepartment of Onco-Hematology, Henri Duffaut hospital, Avignon.
Marie-Odile PétillonIntergroupe Francophone du Myélome, Paris.
Sandrine RolletIntergroupe Francophone du Myélome, Paris.
Helene GardeneyUniversity, U1313, U1402, Poitiers.
Geraldine DurandUniversity, U1313, U1402, Poitiers.
Anthony LevyDepartment of Onco-Hematology, hospital, Vichy.
Cyrille TouzeauDepartment of clinical Hematology, University hospital, Hôtel Dieu, Nantes.
Aurore PerrotDepartment of Hematology, CRCT INSERM 1037, University hospital, IUCT-O, Toulouse.
Philippe MoreauDepartment of clinical Hematology, University hospital, Hôtel Dieu, Nantes.
Thierry FaconDepartment of Hematology, University hospital and INSERM UMR-S1277, Lille.
Jill CorreUnit for Genomics in Myeloma, CRCT INSERM 1037, University hospital, IUCT-O, Toulouse.
Stephanie RagotClinical investigation center CIC INSERM 1402, University hospital, Poitiers.
Herve Avet-LoiseauUnit for Genomics in Myeloma, CRCT INSERM 1037, University hospital, IUCT-O, Toulouse.
Xavier LeleuUniversity, U1313, U1402, Poitiers. xavier.leleu@chu-poitiers.fr.

Funding

Targeting Genomic Instability and Evolution in MyelomaP01CA155258 · NCI · DANA-FARBER CANCER INST · PI Jill Corre · 2011 to 2026
$32.5M
NCI NIH HHS P01 CA155258
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39540213
PMCPMC11873707

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.